These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 12710764)

  • 1. Differing opinions on value of PIVKA test.
    Giger U
    J Am Vet Med Assoc; 2003 Apr; 222(8):1070; author reply 1070-1. PubMed ID: 12710764
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of a test for proteins induced by vitamin K absence or antagonism in diagnosis of anticoagulant poisoning in dogs: 325 cases (1987-1997).
    Mount ME; Kim BU; Kass PH
    J Am Vet Med Assoc; 2003 Jan; 222(2):194-8. PubMed ID: 12555983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathological features of anticoagulant rodenticide intoxications in dogs.
    Petterino C; Paolo B; Tristo G
    Vet Hum Toxicol; 2004 Apr; 46(2):70-5. PubMed ID: 15080206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of prothrombin time and activated partial thromboplastin time in citrated whole blood samples from clinically ill dogs following storage.
    Maunder CL; Costa M; Cue SM; Crawford EM; Papasouliotis K; Murphy KF
    J Small Anim Pract; 2012 Sep; 53(9):531-5. PubMed ID: 22860986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pericardial effusion and cardiac tamponade secondary to brodifacoum toxicosis in a dog.
    Petrus DJ; Henik RA
    J Am Vet Med Assoc; 1999 Sep; 215(5):647-8. PubMed ID: 10476710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective characterization of canine coagulopathies using the turbidimetric ACL-TOP 300 analyzer (2014-2015): Forty-seven dogs.
    Richardson R; Todd JM; Sharkey LC; Washabau RJ; Williams KD; Little KJ; Rendahl A
    J Vet Emerg Crit Care (San Antonio); 2018 Nov; 28(6):551-558. PubMed ID: 30320489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation disorders in dogs with hepatic disease.
    Prins M; Schellens CJ; van Leeuwen MW; Rothuizen J; Teske E
    Vet J; 2010 Aug; 185(2):163-8. PubMed ID: 19487141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of second-generation rodenticides (in case of brodifacum)].
    Denisenko VI; Shutova MI
    Med Parazitol (Mosk); 2008; (2):49-52. PubMed ID: 18561407
    [No Abstract]   [Full Text] [Related]  

  • 10. Contact factor deficiency in a German Shorthaired Pointer without clinical evidence of coagulopathy.
    Lisciandro GR; Brooks M; Catalfamo JL
    J Vet Intern Med; 2000; 14(3):308-10. PubMed ID: 10830545
    [No Abstract]   [Full Text] [Related]  

  • 11. Brodifacoum toxicosis in two horses.
    McConnico RS; Copedge K; Bischoff KL
    J Am Vet Med Assoc; 1997 Oct; 211(7):882-6. PubMed ID: 9333092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant rodenticide screening in dogs: 123 cases (1996-2003).
    Waddell LS; Poppenga RH; Drobatz KJ
    J Am Vet Med Assoc; 2013 Feb; 242(4):516-21. PubMed ID: 23363284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Case report. Phenprocoumon (Marcumar, Falithrom) as an unusual reason for coumarin poisoning in a dog].
    Lutze G; Römhild W; Elwert J; Leppelt J; Kutschmann K
    Dtsch Tierarztl Wochenschr; 2003 Jan; 110(1):31-3. PubMed ID: 12596669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemostatic disorders as a complication of autoimmune hemolytic anemia in dogs].
    Mischke R
    Dtsch Tierarztl Wochenschr; 1998 Jan; 105(1):13-6. PubMed ID: 9499627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical analysis of 12 patients caused by long-acting anticoagulant rodenticide occult poisoning.
    Cao X; Li L; Zheng Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):849-53. PubMed ID: 22954910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agreement of point-of-care prothrombin and activated partial thromboplastin time in dogs with a reference laboratory.
    Yang W; Hosgood G; Luobikis K; Paul A
    Aust Vet J; 2018 Oct; 96(10):379-384. PubMed ID: 30255579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of prothrombin time and activated partial thromboplastin time in dogs with hepatic disease.
    Badylak SF; Van Vleet JF
    Am J Vet Res; 1981 Dec; 42(12):2053-6. PubMed ID: 7340574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation abnormalities associated with acute Angiostrongylus vasorum infection in dogs.
    Schelling CG; Greene CE; Prestwood AK; Tsang VC
    Am J Vet Res; 1986 Dec; 47(12):2669-73. PubMed ID: 3800129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a point-of-care coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and activated clotting time in dogs.
    Tseng LW; Hughes D; Giger U
    Am J Vet Res; 2001 Sep; 62(9):1455-60. PubMed ID: 11560277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a prothrombin time optimized for the dog on plasmas with defined coagulation factor deficiency due to coumarin intoxication.
    Mischke R
    Zentralbl Veterinarmed A; 1995 Nov; 42(9):589-99. PubMed ID: 8822195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.